The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drug of Abuse (DOA) Testing Equipment Market Research Report 2025

Global Drug of Abuse (DOA) Testing Equipment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1417293

No of Pages : 86

Synopsis
The drug of abuse test is an immunoassay based on the principle of competitive binding. This report mainly focuses on drug of abuse (DOA) testing equipment market.
The global Drug of Abuse (DOA) Testing Equipment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Drugs of abuse testing equipment such as immunoassays are widely used because they are a fast, cheap and convenient way to screen large numbers of samples in various matrices. North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
This report aims to provide a comprehensive presentation of the global market for Drug of Abuse (DOA) Testing Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug of Abuse (DOA) Testing Equipment.
Report Scope
The Drug of Abuse (DOA) Testing Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug of Abuse (DOA) Testing Equipment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug of Abuse (DOA) Testing Equipment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens AG
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Others
Segment by Application
Hospitals
Laboratories
Workplace
At-Home
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug of Abuse (DOA) Testing Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug of Abuse (DOA) Testing Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Drug of Abuse (DOA) Testing Equipment Market Overview
1.1 Product Overview and Scope of Drug of Abuse (DOA) Testing Equipment
1.2 Drug of Abuse (DOA) Testing Equipment Segment by Type
1.2.1 Global Drug of Abuse (DOA) Testing Equipment Market Value Comparison by Type (2024-2030)
1.2.2 Immunoassay Analyzers
1.2.3 Chromatography Instruments
1.2.4 Breath Analyzers
1.2.5 Others
1.3 Drug of Abuse (DOA) Testing Equipment Segment by Application
1.3.1 Global Drug of Abuse (DOA) Testing Equipment Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Workplace
1.3.5 At-Home
1.4 Global Drug of Abuse (DOA) Testing Equipment Market Size Estimates and Forecasts
1.4.1 Global Drug of Abuse (DOA) Testing Equipment Revenue 2019-2030
1.4.2 Global Drug of Abuse (DOA) Testing Equipment Sales 2019-2030
1.4.3 Global Drug of Abuse (DOA) Testing Equipment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug of Abuse (DOA) Testing Equipment Market Competition by Manufacturers
2.1 Global Drug of Abuse (DOA) Testing Equipment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug of Abuse (DOA) Testing Equipment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug of Abuse (DOA) Testing Equipment Average Price by Manufacturers (2019-2024)
2.4 Global Drug of Abuse (DOA) Testing Equipment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug of Abuse (DOA) Testing Equipment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug of Abuse (DOA) Testing Equipment, Product Type & Application
2.7 Drug of Abuse (DOA) Testing Equipment Market Competitive Situation and Trends
2.7.1 Drug of Abuse (DOA) Testing Equipment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug of Abuse (DOA) Testing Equipment Players Market Share by Revenue
2.7.3 Global Drug of Abuse (DOA) Testing Equipment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug of Abuse (DOA) Testing Equipment Retrospective Market Scenario by Region
3.1 Global Drug of Abuse (DOA) Testing Equipment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug of Abuse (DOA) Testing Equipment Global Drug of Abuse (DOA) Testing Equipment Sales by Region: 2019-2030
3.2.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Region: 2019-2024
3.2.2 Global Drug of Abuse (DOA) Testing Equipment Sales by Region: 2025-2030
3.3 Global Drug of Abuse (DOA) Testing Equipment Global Drug of Abuse (DOA) Testing Equipment Revenue by Region: 2019-2030
3.3.1 Global Drug of Abuse (DOA) Testing Equipment Revenue by Region: 2019-2024
3.3.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Region: 2025-2030
3.4 North America Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.4.1 North America Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.4.3 North America Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.5.1 Europe Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.5.3 Europe Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.6.1 Asia Pacific Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.7.1 Latin America Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.7.3 Latin America Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug of Abuse (DOA) Testing Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug of Abuse (DOA) Testing Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug of Abuse (DOA) Testing Equipment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug of Abuse (DOA) Testing Equipment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Type (2019-2030)
4.1.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Type (2019-2024)
4.1.2 Global Drug of Abuse (DOA) Testing Equipment Sales by Type (2025-2030)
4.1.3 Global Drug of Abuse (DOA) Testing Equipment Sales Market Share by Type (2019-2030)
4.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Type (2019-2030)
4.2.1 Global Drug of Abuse (DOA) Testing Equipment Revenue by Type (2019-2024)
4.2.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Type (2025-2030)
4.2.3 Global Drug of Abuse (DOA) Testing Equipment Revenue Market Share by Type (2019-2030)
4.3 Global Drug of Abuse (DOA) Testing Equipment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Application (2019-2030)
5.1.1 Global Drug of Abuse (DOA) Testing Equipment Sales by Application (2019-2024)
5.1.2 Global Drug of Abuse (DOA) Testing Equipment Sales by Application (2025-2030)
5.1.3 Global Drug of Abuse (DOA) Testing Equipment Sales Market Share by Application (2019-2030)
5.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Application (2019-2030)
5.2.1 Global Drug of Abuse (DOA) Testing Equipment Revenue by Application (2019-2024)
5.2.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Application (2025-2030)
5.2.3 Global Drug of Abuse (DOA) Testing Equipment Revenue Market Share by Application (2019-2030)
5.3 Global Drug of Abuse (DOA) Testing Equipment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Siemens AG
6.1.1 Siemens AG Corporation Information
6.1.2 Siemens AG Description and Business Overview
6.1.3 Siemens AG Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Siemens AG Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.1.5 Siemens AG Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Bio-Rad
6.5.1 Bio-Rad Corporation Information
6.5.2 Bio-Rad Description and Business Overview
6.5.3 Bio-Rad Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bio-Rad Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.5.5 Bio-Rad Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Abbott Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Quest Diagnostics
6.6.1 Quest Diagnostics Corporation Information
6.6.2 Quest Diagnostics Description and Business Overview
6.6.3 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.7.5 Quest Diagnostics Recent Developments/Updates
6.8 Psychemedics
6.8.1 Psychemedics Corporation Information
6.8.2 Psychemedics Description and Business Overview
6.8.3 Psychemedics Drug of Abuse (DOA) Testing Equipment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Psychemedics Drug of Abuse (DOA) Testing Equipment Product Portfolio
6.8.5 Psychemedics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug of Abuse (DOA) Testing Equipment Industry Chain Analysis
7.2 Drug of Abuse (DOA) Testing Equipment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug of Abuse (DOA) Testing Equipment Production Mode & Process
7.4 Drug of Abuse (DOA) Testing Equipment Sales and Marketing
7.4.1 Drug of Abuse (DOA) Testing Equipment Sales Channels
7.4.2 Drug of Abuse (DOA) Testing Equipment Distributors
7.5 Drug of Abuse (DOA) Testing Equipment Customers
8 Drug of Abuse (DOA) Testing Equipment Market Dynamics
8.1 Drug of Abuse (DOA) Testing Equipment Industry Trends
8.2 Drug of Abuse (DOA) Testing Equipment Market Drivers
8.3 Drug of Abuse (DOA) Testing Equipment Market Challenges
8.4 Drug of Abuse (DOA) Testing Equipment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’